These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 17161050

  • 1. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
    Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC, Wang SY, Hung A, Cherng WJ.
    Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation.
    George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, Herz I, Miller H, Keren G.
    Eur Heart J; 2004 Jun; 25(12):1003-8. PubMed ID: 15191769
    [Abstract] [Full Text] [Related]

  • 5. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U.
    Circulation; 2007 Jul 10; 116(2):163-73. PubMed ID: 17592079
    [Abstract] [Full Text] [Related]

  • 6. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
    Werner C, Kamani CH, Gensch C, Böhm M, Laufs U.
    Diabetes; 2007 Oct 10; 56(10):2609-15. PubMed ID: 17623816
    [Abstract] [Full Text] [Related]

  • 7. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G, Issa M, Vlajnic A.
    Curr Med Res Opin; 2006 Apr 10; 22(4):751-9. PubMed ID: 16684436
    [Abstract] [Full Text] [Related]

  • 8. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia.
    Zhu J, Wang X, Chen J, Sun J, Zhang F.
    Arch Med Res; 2006 May 10; 37(4):484-9. PubMed ID: 16624647
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.
    Fadini GP, Pagano C, Baesso I, Kotsafti O, Doro D, de Kreutzenberg SV, Avogaro A, Agostini C, Dorigo MT.
    Acta Ophthalmol; 2010 Feb 10; 88(1):135-41. PubMed ID: 19549102
    [Abstract] [Full Text] [Related]

  • 11. Daily intake of thiamine correlates with the circulating level of endothelial progenitor cells and the endothelial function in patients with type II diabetes.
    Wong CY, Qiuwaxi J, Chen H, Li SW, Chan HT, Tam S, Shu XO, Lau CP, Kwong YL, Tse HF.
    Mol Nutr Food Res; 2008 Dec 10; 52(12):1421-7. PubMed ID: 18925614
    [Abstract] [Full Text] [Related]

  • 12. Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head.
    Feng Y, Yang SH, Xiao BJ, Xu WH, Ye SN, Xia T, Zheng D, Liu XZ, Liao YF.
    Bone; 2010 Jan 10; 46(1):32-40. PubMed ID: 19747991
    [Abstract] [Full Text] [Related]

  • 13. Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients.
    Makino H, Okada S, Nagumo A, Sugisawa T, Miyamoto Y, Kishimoto I, Akie TK, Soma T, Taguchi A, Yoshimasa Y.
    Diabetes Res Clin Pract; 2008 Sep 10; 81(3):327-30. PubMed ID: 18639363
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia.
    Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH.
    Clin Sci (Lond); 2004 Sep 10; 107(3):273-80. PubMed ID: 15099190
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.
    Metabolism; 2003 Feb 10; 52(2):173-80. PubMed ID: 12601628
    [Abstract] [Full Text] [Related]

  • 19. Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.
    Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC.
    Eur J Pharmacol; 2011 Jun 01; 659(2-3):296-301. PubMed ID: 21453695
    [Abstract] [Full Text] [Related]

  • 20. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R, Kondos GT, Perez A, Chen Z, Mazzone T.
    Circulation; 2008 Apr 22; 117(16):2123-30. PubMed ID: 18413496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.